Adzymes and uses thereof

Details for Australian Patent Application No. 2005219878 (hide)

International Classifications

Event Publications

19 October 2006 PCT application entered the National Phase

PCT publication WO2005/085430 Priority application(s): WO2005/085430

16 August 2007 Change of Name(s) of Applicant(s), Section 104

Compound Therapeutics, Inc. The name of the applicant has been changed to Adnexus Therapeutics, Inc.

29 May 2008 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read Wong, Gordon G.; Afeyan, Noubar B.; Das Gupta, Ruchira; Baynes, Brian; Camphausen, Ray and Lee, Frank D.

8 January 2009 Assignment before Grant

Adnexus Therapeutics, Inc. The application has been assigned to Bristol-Myers Squibb Company

8 October 2009 Application Accepted

Published as AU-B-2005219878

4 February 2010 Standard Patent Sealed

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.